Wednesday, July 30th, 2025

Optimax Holdings Eyes Steady Growth with Promising Technical Signals

Date: October 21, 2024
Broker: CGS International Securities Malaysia Sdn. Bhd.

Company Overview

Optimax Holdings is a leading provider of eye care services in Malaysia. The company operates a network of specialist centers, offering a wide range of services including cataract surgery, LASIK, and other vision correction procedures. Optimax has built a strong reputation for its high-quality eye care solutions, catering to both local and international clients.

Recent Stock Performance

  • Last Price: RM 0.690
  • Optimax Holdings’ stock has been trading close to its entry price, reflecting a period of stability. Although the stock has seen slight fluctuations, it remains a part of the actively managed portfolio, indicating confidence in its future performance.

Technical Analysis

  • Entry Price: RM 0.695
  • Current Price: RM 0.690
  • Stop Loss: RM 0.630
  • Target Prices: RM 0.77, RM 0.795

Trading Position

  • Current Position: Buy
  • Weighting in Portfolio: 6%
  • Shares Held: 115,100
  • Total Cost: RM 79,994.50
  • Market Value: RM 79,419.00
  • Profit/Loss: -RM 575.50 (-0.7%)

Trading Recommendation

Optimax Holdings is retained as a “Buy” within the actively managed portfolio despite a minor loss. The stop-loss is set at RM 0.630, ensuring that downside risks are managed effectively. The stock has target prices of RM 0.77 and RM 0.795, reflecting potential areas for recovery and profit. Investors are advised to keep a close watch on price movements, especially as the stock approaches the key resistance levels.

Conclusion

Optimax Holdings continues to demonstrate stability in its stock performance, with potential for growth as indicated by its technical setup. The company’s strong presence in the eye care sector and the strategic inclusion in the portfolio suggest optimism for future gains. Traders should monitor support and resistance levels closely, adhering to the stop-loss to safeguard against any adverse movements.

Parkway Life REIT (PLIFE) Stock Analysis: BUY Rating, DPU Growth & Fair Value Update (April 2025)

OCBC Investment Research Private Limited 23 April 2025 Parkway Life REIT: Solid Growth and Defensive Portfolio Drive “BUY” Rating Investment Thesis: A Healthcare REIT with Growth Potential ] Parkway Life REIT (PLIFE) stands out...

Singapore Property Sentiment Turns Positive as Interest Rates Ease: What Investors Need to Know

Lim & Tan Securities: An In-Depth Analysis of Market Trends and Company Performances Date of Report: 27 November 2024 Broker Name: Lim & Tan Securities Market Overview and Key Insights The latest report by...

Xiaomi Surpasses Apple, Secures Global No. 2 Spot in Smartphone Market

Date: 24 September 2024Broker: MIB Securities (Hong Kong) Ltd Xiaomi’s Global Ranking According to Counterpoint Research, Xiaomi has surpassed Apple in terms of global smartphone sell-through volumes as of August 2024, making it the...